28 candidate genes (8 potential causal genes with ≥ 2 lines of evidence) 11 unique sentinel variants + proxies (LD r 2 ≥ 0.8)
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVSV, left ventricular stroke volume; LVM, left ventricular mass; LVMVR, left ventricular mass to end-diastolic volume ratio; LVEF, left ventricular ejection fraction; SNV, single nucleotide variant; REML, restricted maximal likelihood; SBP, systolic blood pressure; MAF, minor allelic frequency; INFO, imputation quality score; LD, linkage disequilibrium; GCTA, genome-wide complex trait analysis; DBP, diastolic blood pressure; BMI, body mass index; CMR, cardiovascular magnetic resonance imaging; MESA, multi-ethnic study of atherosclerosis; Hi-C, long-range chromatin interaction analysis; FUMA, Functional Mapping and Annotation tool; eQTL, expression quantitative trait loci; GTEx, Genotype-Tissue Expression database; DEPICT, Data-driven Expression-Prioritised Integration for Complex Traits; Recombination rate (cM/Mb) Recombination rate (cM/Mb) Recombination rate (cM/Mb) Recombination rate (cM/Mb) Recombination rate (cM/Mb) Recombination rate (cM/Mb) Figure 10 . Cumulative incidence of heart failure stratified by LV-PRS quintiles
SNPs in DNase1 sites (probably TF sites) in cell lines for all_LV_variants_1E05
The hazard ratios compared PRS quintile 5 (Highest 20%) vs quintile 1 (Lowest 20%) and were obtained from the multivariate Cox regression models adjusted for age, sex, BMI, SBP and DBP corrected for anti-hypertensive medication use, smoking status, regular alcohol use, dyslipidaemia, diabetes and 15 PCs. There was no significance difference in the incidence of heart 
